non glp 1 weight loss medication Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 weight loss drugs to

But the real future of obesity medicine may not simply be stronger drugs. It may be personalized metabolic treatment based on: patient profile muscle mass inflammation markers insulin resistance long-term sustainability The era of precision metabolic medicine is only beginning

And it takes more than just a prescription to achieve sustained weight loss and the health benefits that go along with it

DUAL V Investigators

The American Cancer Society and WHO's Global Cancer Statistics 2026 released earlier this month documented the scale of the chronic disease burden heading toward 2050

Given the high prevalence of fatty liver in diabetic patients (estimated at 5570%), initiating or switching to a GLP-1 agonist addresses both conditions simultaneously

doi: 10.1002/oby.24336